Investments
188Portfolio Exits
62Funds
6Service Providers
3About Aisling Capital
Aisling Capital, a private equity firm, believes the next decade will be marked by a revolution in healthcare driven by new therapeutics generated by biotechnology. The completion of the human genome has given scientists new insights into the causes of human disease. These insights, combined with the past 20 years of developments in the biotechnology industry, are leading to rapid expansion of novel approaches toward the diagnosis, prevention, and treatment of life-threatening illnesses. These advances have led to an ever-increasing demand for capital to complete the development and commercialization of new therapeutics. The Firm's goal is to support the leading global healthcare companies that are building on these technical and medical breakthroughs to commercialize new healthcare products.
Latest Aisling Capital News
Oct 25, 2024
Venture Capital The deal comes a day after the private equity firm announced a majority stake in the $8.5 billion Americana Partners, a member of the Dynasty Financial Partners network.
Aisling Capital Investments
188 Investments
Aisling Capital has made 188 investments. Their latest investment was in Wugen as part of their Series C on August 27, 2025.
Aisling Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
8/27/2025 | Series C | Wugen | $115M | No | Fidelity Investments, Lightchain Capital, LYZZ Capital, RiverVest Venture Partners, Tybourne Capital Management, and Undisclosed Investors | 4 |
10/17/2024 | Series A - III | Treeline | $200M | Yes | AI Life Sciences Investments, Ajax Health, ARCH Venture Partners, Casdin Capital, Exor, Fidelity Investments, Google Ventures, KKR, OrbiMed, Rock Springs Capital, and T. Rowe Price | 2 |
8/22/2024 | Series A | GondolaBio | $300M | Yes | 4 | |
8/22/2024 | Series A | |||||
5/2/2024 | Private Equity |
Date | 8/27/2025 | 10/17/2024 | 8/22/2024 | 8/22/2024 | 5/2/2024 |
|---|---|---|---|---|---|
Round | Series C | Series A - III | Series A | Series A | Private Equity |
Company | Wugen | Treeline | GondolaBio | ||
Amount | $115M | $200M | $300M | ||
New? | No | Yes | Yes | ||
Co-Investors | Fidelity Investments, Lightchain Capital, LYZZ Capital, RiverVest Venture Partners, Tybourne Capital Management, and Undisclosed Investors | AI Life Sciences Investments, Ajax Health, ARCH Venture Partners, Casdin Capital, Exor, Fidelity Investments, Google Ventures, KKR, OrbiMed, Rock Springs Capital, and T. Rowe Price | |||
Sources | 4 | 2 | 4 |
Aisling Capital Portfolio Exits
62 Portfolio Exits
Aisling Capital has 62 portfolio exits. Their latest portfolio exit was Verona Pharma on October 07, 2025.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
10/7/2025 | Acq - P2P | 12 | |||
8/11/2025 | Reverse Merger | Helix Acquisition II | 5 | ||
9/13/2024 | IPO | Public | 7 | ||
Date | 10/7/2025 | 8/11/2025 | 9/13/2024 | ||
|---|---|---|---|---|---|
Exit | Acq - P2P | Reverse Merger | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | Helix Acquisition II | Public | |||
Sources | 12 | 5 | 7 |
Aisling Capital Fund History
6 Fund Histories
Aisling Capital has 6 funds, including Aisling Capital V.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
6/25/2020 | Aisling Capital V | Late-Stage Venture Capital | Open | $144.15M | 2 |
11/2/2017 | Aisling Capital Healthcare | ||||
7/19/2016 | Aisling Capital IV | ||||
12/31/2008 | Aisling Capital III LP | ||||
12/22/2005 | Aisling Capital II LP |
Closing Date | 6/25/2020 | 11/2/2017 | 7/19/2016 | 12/31/2008 | 12/22/2005 |
|---|---|---|---|---|---|
Fund | Aisling Capital V | Aisling Capital Healthcare | Aisling Capital IV | Aisling Capital III LP | Aisling Capital II LP |
Fund Type | Late-Stage Venture Capital | ||||
Status | Open | ||||
Amount | $144.15M | ||||
Sources | 2 |
Aisling Capital Service Providers
3 Service Providers
Aisling Capital has 3 service provider relationships
Service Provider | Associated Rounds | Provider Type | Service Type |
|---|---|---|---|
Accounting Firm | |||
Service Provider | |||
|---|---|---|---|
Associated Rounds | |||
Provider Type | Accounting Firm | ||
Service Type |
Partnership data by VentureSource
Aisling Capital Team
9 Team Members
Aisling Capital has 9 team members, including current Chief Financial Officer, Lloyd E. Appel.
Name | Work History | Title | Status |
|---|---|---|---|
Lloyd E. Appel | Chief Financial Officer | Current | |
Name | Lloyd E. Appel | ||||
|---|---|---|---|---|---|
Work History | |||||
Title | Chief Financial Officer | ||||
Status | Current |
Loading...